# Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users

> **NCT04110535** · PHASE1 · COMPLETED · sponsor: **Paion UK Ltd.** · enrollment: 83 (actual)

## Conditions studied

- Abuse, Drug

## Interventions

- **DRUG:** Remimazolam
- **DRUG:** Midazolam
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT04110535
- **Lead sponsor:** Paion UK Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-23
- **Primary completion:** 2015-10-06
- **Final completion:** 2015-10-06
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2019-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110535, "Abuse Potential of Intravenous Remimazolam Compared to Midazolam and Placebo in Recreational CNS Depressant Users". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04110535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*